NDC11 45963061455
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 45963-0614-55 | 45963-0614 |
| 45963-614-55 | 45963-614 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Irinotecan hydrochloride | IRINOTECAN HYDROCHLORIDE | Actavis Pharma, Inc. | 5e1fdcaa-918f-4cd8-9c7a-4c538d866198 | 2025-05-31 | Boxed warning, Warnings, Adverse reactions | 45963-614-55 45963-614 45963061455 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.